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Abstract
Oligosaccharides are carbohydrates,  composed of up to twenty monosaccharides
linked by glycosydic bonds, widely used in food and pharmaceutical industries.
These  compounds  can  be  obtained  by  extraction  from  natural  sources  (milk,
vegetables, fruits), and by chemical or biotechnological processes. In the last case,
chemical structures and composition of the generated oligosaccharides depend on
the type and source of enzymes, and on process conditions, including the initial
concentration of substrate. Among the various functions of nondigestible oligosac‐
charides,  one that has attracted attention is  its  prebiotic  potential.  The intestinal
benefits  of  prebiotics,  such as  fructooligosaccharides  and inulin  as  well  as  their
symbiotic  association  with  probiotic  bacteria,  encompass  prevention  and  treat‐
ment  of  infectious  diseases,  including  viral  or  bacterial  diarrhea,  and  chronic
inflammatory  diseases  such  as  ulcerative  colitis.  Other  benefits  attributed  to
prebiotics and probiotics include treatment of inflammatory intestinal and irritable
bowel  syndrome,  prevention of  cancer,  and modulation of  the  immune system,
mineral absorption and lipid metabolism. Fructooligosaccharides (FOS), galactooli‐
gosaccharides  (GOS)  and chitooligosaccharides  (COS)  have been widely studied
for  their  prebiotic  properties.  Moreover,  novel  oligosaccharides  with  potential
prebiotic activity are currently under investigation. This review will focus mainly
on  the  biotechnological  production,  health  benefits  and  applications  of  non-
natural oligosaccharides in the food industry.
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1. Introduction
Consumers all around the world are increasingly aware and concerned about safety and the
quality of food. Besides the push towards replacement of chemical additives by those obtained
from natural sources, this awareness has led to a rising demand for enrichment of foods with
bioactive compounds that have beneficial effects on human health [1]. Therefore, nowadays,
a variety of gluten free and products enriched with dietary fiber, or containing probiotics and/
or prebiotic and functional oligosaccharides are available in the market [2].
Oligosaccharides are carbohydrates, composed of up to twenty monosaccharides linked by
glycosydic bonds, widely used in food and pharmaceutical industries. These compounds are
obtained from natural sources and through chemical or biotechnological processes [3,4].
Among the various functions of non-digestible oligosaccharides, one that has attracted
attention is its prebiotic potential. A prebiotic can be defined as “selectively fermented
ingredients that allow specific changes, both in the composition and/or activity in the gastro‐
intestinal microbiota that confers benefits upon host well-being and health” [5]. An oligosac‐
charide to be regarded as prebiotic must not be hydrolyzed or absorbed in the upper part of
the gastrointestinal tract; and must be assimilated selectively by one or by a limited number
of beneficial microorganisms in the colon, promoting benefic luminal or systemic effects. To
improve colonic function, live microorganisms can be administered in adequate amounts,
being known as probiotics; and to be used in food, these organisms must be able to survive
passage through the gut; to proliferate and to colonize the digestive tract; and must be safe
and effective [6,7].
The intestinal benefits of prebiotics, such as fructooligosaccharides and inulin as well as their
symbiotic association with probiotic bacteria, encompass prevention and treatment of
infectious diseases, including viral or bacterial diarrhea, and chronic inflammatory diseases
such as ulcerative colitis [8]. The mechanisms of action of probiotics against gastrointestinal
pathogens consist mainly on competition for nutrients and sites of access, production of
antimicrobial metabolites, changes in environmental conditions, and modulation of the
immune response of the host. Other benefits attributed to prebiotics and probiotics include
treatment of inflammatory intestinal and irritable bowel syndrome, prevention of cancer, and
modulation of the immune system, mineral absorption and lipid metabolism [8,9].
Oligosaccharides can be obtained by extraction from natural sources (milk, vegetables, fruits),
and by chemical or biotechnological processes [10,11]. Mixtures of oligosaccharides with
different degrees of polymerization and glycosidic linkages are usually formed in the enzy‐
matic processes. Chemical structures and composition of these mixtures depend on the type
and source of enzymes, and on process conditions, including the initial concentration of
substrate [11,12]. Depending on the initial substrate, production of oligosaccharides can
involve different steps: hydrolysis of glycosidic bonds giving rise to monomers, followed by
generation of disaccharides and other oligomers through the action of transferases [13,14].
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2. Fructooligosaccharides
Fructans are carbohydrates in which one or more fructosylfructose links constitute the majority
of glycosidic bonds [15]. These carbohydrates can be of the inulin-type with β-(2,1)-D-
fructofuranosyl units, found in plants and synthesized by fungi. Additionally, there are the
levan-type fructans with β-(6,2)-D-fructofuranosyl units, found in plants and synthesized by
bacteria [16].
Levan is a polymer with very high molecular weight that can reach 107 Da [17]. In contrast to
levan, inulin from chicory consists of a mixture of oligomers and polymers with a degree of
polymerization (DP) that varies from two to approximately sixty units (Figure 1; Table 1) [18].
Around 10% of the fructan chains in native chicory inulin have a DP in the range between two
and five [5].
Figure 1. Structure of inulin, a linear fructosyl polymer linked by β-(2,1) bonds (n=3-65), attached to a terminal gluco‐
syl residue by an α-(1,2) bond.
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Prebiotics Chemical structure Properties Applicability /
Health benefits
Reference
FOS Fructosyl units linked by β-
(2,1) bonds, attached to a
terminal glucosyl residue
by α-(1,2) bond
(Variants: Inulin type β-1,2
and Levan type β-2,6
linkages between fructosyl
units in the main chain)
DP=3-10.
Soluble fibers;
Gel formation;
Sugar replacement;
Moderate sweetness;
Stable (depending on
matrix).
Prevention of intestinal infections
and extra intestinal infections (e.g.
respiratory tract;
Inhibition of pathogens, ordering
intestinal flora;
Regulation of intestinal immune
system;
Enhancement of immune response;
Stimulation of probiotic growth of
Lactobacilli and Bifidobacteria
species;
Optimization of colonic function and
metabolism;
Production of short chain fatty acids;
Increase of mineral absorption;
Reduction of food intake and obesity
management and control of diabetes
type 2;
Prevention of cancer.
[8,24,25,
61,67,69,
72,170,
176-186]
Inulin Mixture of linear fructosyl
polymers and oligomers
(DP = 3-65) linked by β-(2,1)
bonds, attached to a
terminal glucosyl residue
by α(1—2) bond.
Soluble fiber;
Water adsorption;
Gel formation;
Modifier of viscosity,
texture, colour and
sensory aspects of food
formulations;
Replacement for fat and
sugar;
Low calorimetric value;
Moderate sweetness.
Stimulation of probiotic growth;
Lowering effect on cholesterol LDL
and triglycerides levels;
Influence on inflammatory markers
and development of gut associated
lymphoid tissue (GALT);
Regulation of intestinal immune
system;
Enhancement of immune response;
Increase of mineral absorption
(Calcium, Iron and Magnesium);
Prevention of cancer.
[8,19,67,
176,187-195]
GOS Mixture of
galactopyranosyl oligomers
(DP= 3-8) linked mostly by
β-(1,4) or β-(1,6) bonds,
although low proportions
of β (1,2) or β-(1,3) linkages
may also be present.
Terminal glucosyl residues
Stable in acidic
conditions and in higher
temperatures;
Soluble;
Cryoprotector activity;
Low ability to crystalyze;
Incorporated in various
functional foods.
Stimuli of probiotic growth;
Reorder intestinal flora;
Regulation of intestinal immune
system;
Reinforcement of intestinal barrier;
Inhibition of adhesion of pathogens;
Mimic molecular receptors, inhibit
microbial adherence;
[8,105,
196-
206]
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Prebiotics Chemical structure Properties Applicability /
Health benefits
Reference
are linked by β-(1,4) bonds
to galactosyl units.
Prevent infections (e.g. Clostridium
difficile diarrhea);
Prevention of cancer;
Enhance mineral absorption;
Reduce food intake, helping obesity
management.
Use in diabetic foods, free from
carbohydrates that increase the level
of postprandial glucose;
Use in specialized foods for
individuals intolerant to lactose.
Lactulose Galactosyl β-(1,4) fructose. Sweetener, sugar
replacement;
Induces growth of Bifidobacterium
both in vitro and in vivo;
use as laxative in the treatment of
constipation;
Optimization of colonic function and
metabolism, reducing colon pH and
ammonia concentration;
Increased mineral absorption;
Treatment of portal systemic
encephalophathy and chronic
constipation; Uses in diabetic and
dairy foods.
[205, 207-211]
COS Chitin: β-(1,4) linked N-
acetyl-D-glucosamine
residues; Chitosan: β-(1,4)
linked D-glucosamine
polymer. DP=2-8
Antimicrobial activity of
chitosan depends on
degree of polymerization,
amino groups content
and degree of acetylation;
Chelation of metal trace
elements and essential
nutrients;
Flocculation and
adsorption capacity
mainly because of the
cationic macromolecular
structure.
Antimicrobial and antioxidant
activity;
Use as food preservative;
Use as dietary supplements in
functional foods;
Prebiotic activity;
Hypocholesterolemic;
[149, 212,
213]
Biotechnological Production of Oligosaccharides — Applications in the Food Industry
http://dx.doi.org/10.5772/60934
29
Prebiotics Chemical structure Properties Applicability /
Health benefits
Reference
XOS Xylose oligomers connected
by β-(1,4) linkages
(DP=3-6).
Stable in a large range of
pH values (2,5-8,0);
Thermal stability (up to
100°C);
Antioxidant effects;
Antifreezing activity;
Low cariogenicity;
Low calorimetric value;
Low glycemic index.
Inhibition of pathogens growth,
reordering intestinal flora;
Stimulation of probiotic growth;
Reinforcement of intestinal barrier;
Optimization of colonic function and
metabolism;
Obesity management, reduction of
food intake and weight.
[159, 162, 179,
214-216]
IMO Glucosyl residues linked to
maltose or isomaltose by α-
(1,6) glycosidic bonds.
Low sweetness;
Low viscosity;
Bulking properties;
Humectant;
Prevention of sucrose
crystallization.
Optimization of colonic function and
metabolism, reduces nitrogenated
products;
Increase caecum weight;
Antidiabetic effects;
Improve lipid metabolism and
obesity management.
[2, 217-
219]
SOS Oligomers composed by
galactosyl units linked to
sucrose by α-(1,6) bonds.
Most abundant are
raffinose and stachyose.
Stabilizer properties;
Cryoprotectant effect.
Prevention of pathogen proliferation. [2, 156, 213, 220,
221]
FOS: Fructooligosaccharides; GOS: Galactooligosaccharides; COS: Chitooligosaccharides;
XOS: Xylooligosaccharides; IMO: Isomaltooligosaccharides; SOS: Soybean oligosaccharides
Table 1. Structure and biological activity of prebiotics.
Inulin-type fructooligosaccharides are made up of two or more fructosyl moieties linked by
β-(2,1) bonds and united at the non-reducing end to a terminal glucose residue by an α-(1,2)
glycosidic bond (Table 1) [19]. The term fructooligosaccharides (FOS) is mainly used for
fructose oligomers that contain one glucose unit and from two to four fructose units bound
together by β-(2,1) glycosidic linkages [20,21]. Nevertheless, oligofructose and FOS may be
regarded as synonyms for the mixture of small inulin oligomers with DP<10 [6,22]; while short
chain FOS (sc-FOS) are fructose oligomers mainly composed of 1-kestose (GF2), nystose (GF3),
and 1F-fructofuranosylnystose (GF4) (Figure 2) [23-25].
Fructans have storage and protective functions in many commonly consumed plants, being a
typical part of the diet. Some food sources are richer in high molecular weight fructans, such
as inulin, while others have higher levels of sc-FOS [26].
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FOS are found in low levels in natural sources such as asparagus, sugar beet, garlic, chicory,
onion, Jerusalem artichoke, wheat, honey, banana, barley, tomato, and rye [27-29]. Apart from
usually occurring in low concentrations, seasonal conditions also limit their large-scale
production from these sources [30].
For this reason, enzymatic processes are used for the industrial production of FOS. One route
involves the controlled hydrolysis of long chain fructans (Table 2) [31,32], which results in a
large amount of FOS mostly without glucose in their structures. The other route is the synthesis
from sucrose, which leads to sc-FOS that contain a molecule of glucose in their structures [11,
33]. The present review will focus on the synthesis of FOS from sucrose.
FOS are produced from sucrose by the action of microbial enzymes with high transfuctosy‐
lating activity: β-D-fructosyltransferase (FTase, EC 2.4.1.9) and β-fructofuranosidase (FFase,
EC 3.2.1.26) (Table 2) [34]. Since FTase possesses almost only the transfructosylating activity,
it is able to cleave the β-1,2 linkage of sucrose, transferring the fructosyl group to an acceptor
molecule, with the resulting formation of fructooligosaccharides and release of glucose [35].
This enzyme shows little affinity towards water as an acceptor, therefore the hydrolase activity
of FTase is very low [36].
FFase can catalyze both hydrolytic and transfructosylating reactions, nevertheless, transfruc‐
tosylation only takes place when sucrose concentrations are higher than 500 g L-1 [27,34,36-38].
The production of FOS by the action of FFase on sucrose can occur either by reverse hydrolysis
or by transfructosylation [36].
Figure 2. Structures of typical fructooligosaccharides (FOS), derived from sucrose. FOS consist of a glucosyl residue α-
(1,2) linked to two or more β-(1,2) fructosyl units. Synthesis of these FOS is catalyzed by fructosyltransferases, requir‐
ing a second sucrose molecule as a fructosyl residue donor.
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Type of
prebiotics
Obtention source Enzyme processing Microbial producer Industrial product
and manufacturer
References
FOS Enzymatic reactions:
fructosyltransferases
using sucrose as a
substrate or from
inulin using microbial
endoinulinases.
Fructosyltransferases or
β-fructofuranosidases;
Levansucrases;
Endoinulinases.
B. macerans
Z. mobilis
L. reutri
A. niger
A. japonicus
A. foetidus
A. sydowi
A. pullans
C. purpurea
F. oxysporum
P. citrinum
P. frequentans
P. spinulosum
P. rigulosum
P. parasitica
S. brevicaulis
S. cerevisiae
K. marxianus
Neosugar
Actilight
NutraFlora P-95 -
GTC Nutrition
Raftilose P95 -
Orafti Group
[21,29, 170, 176,
222]
Inulin Natural product,
extraction from plants
Not applicable Not apllicable Inulin-S –
SigmaAldrich
Fibruline - Trades
S.A.
Fibrex - Danisco
Sugar
Frutafit CLR DP8,
Fruta- fit HD DP10,
Frutafit TEX DP5,
Inulin TEX –
Sensus
Inulin GR, HP, HP-
gel, HPX, LS, ST,
Raftilin ST,
Raftilose P95,
Raftiline HP -
Orafti Group
[189, 194, 222]
GOS Enzymatic
transgalactosylation
reactions, using
lactose as substrate;
Fermentation process.
β-Galactosidases Aspergillus sp.
Bacillus sp.
B. circulans
Kluyveromyces sp.
B. bifidum
Vivinal GOS Syrup
- Bolculo Domo or
Friesland Foods
Domo
[105,120, 198,
202-205, 223-
227]
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Type of
prebiotics
Obtention source Enzyme processing Microbial producer Industrial product
and manufacturer
References
S. singularis
S. thermophilus
C. laurentii
Purimune - GTC
Nutrition
Oligomate 55NP -
Yakult
Pharmaceutical Inc.
Cup Oligo H-70®
Kowa Company
BiMuno - Clasado
Ltd.
Lactulose Thermal-alkaline
isomerisation of
lactose;
Enzymatic
transgalactosylation
of fructose.
β-Galactosidases
β-Glycosidases
A. oryzae
S. fragilis
K. lactis
P. furiosus
S. solfataricus
Sigma Aldrich
Discovery Fine
Chemicals
Solvay
[209, 210,
228-230]
XOS Enzymatic
degradation of xylans
Endo-β-1,4-xylanases,
exo-β-1,4-xylosidases,
α-glucuronosidases,
α-L-arabinofuranosidases,
acetylxylan esterases, ferulic
acid esterases and p-
coumaric acid esterases.
T. reesei
T. harzianu
T. viride
T. koningii
T. longibrachiatum
P. chyrosporium
G. trabeum
A. oryzae
Xylooligo™-
Suntory Ltd.
YOGHURINA -
Suntory Ltd.
MARUSHIGE
GENKISU -
Marushige Ueda
Co.
L-ONE - Enzamin
Laboratory Inc.
SUKKIRI KAICHO
Lotte Co.
[152, 159, 232]
COS Enzymatic or
chemical
depolimerization and
deacetylation
of chitin and chitosan
Chitosanases and other non-
specific enzymes (papain,
and lysozyme)
S. coelicolor
B. pumilus
Bacillus sp.
S. kurssanocii
Qingdao BZ-Oligo
Co, Ltd.
BioCHOS.
AMSBIO
[213
232-235]
SOS Directly extracted
from soybean
Not applicable Not applicable Soya-oligo - The
Calpis Food
Industry Co.
[152]
IMO Enzymatic hydrolysis
of starch
α-Amylases or pullulanases,
β-amylases and α-
glucosidases in sequence.
Pullulanases
A. niger
Bacillus spp.
B.subtilis
B. stearothermophilus
Isomalto-900 -
Showa Sangyo
[12, 152,
159, 236]
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Type of
prebiotics
Obtention source Enzyme processing Microbial producer Industrial product
and manufacturer
References
and T. maritima
A. carbonarious
L. mesenteroides
Table 2. Obtention and industrial production of prebiotics.
FOS are produced at industrial scale from concentrated sucrose solutions using fungal
transfructosylating enzymes mainly from strains of Aspergillus niger, Aspergillus oryzae and
Aureobasidium pullulans [27,29,30]. Moreover, production of FTase from bacteria (Lactobacillus)
and yeasts (Rhodotorula, Candida, Cryptococcus sp) has been reported [39,40]. The main enzymes
used for industrial production of FOS generally give rise to a mixture of molecules with the
inulin-type structure, 1F-FOS, whereas those from yeasts usually form levan-type FOS (6F-FOS)
or neoFOS (6G-FOS) [41].
The enzymes from Aureobasidium pullulans and from Aspergillus niger are highly regiospecific
in the fructosyl transfer reaction, transferring one fructosyl moiety from sucrose to the 1-OH
of the furanoside of another fructose molecule or fructooligosaccharide, with high selectivity
[27]. This synthesis is a complex process in which several reactions occur simultaneously, both
in parallel and in series, because sc-FOS are also potential substrates of FTase [42].
Catalytic and physicochemical properties of the producing enzymes, as well as production
conditions and composition of FOS are different, depending on the microbial strain. For
instance, fungal FTases have molecular masses ranging between 180,000 and 600,000, and are
homopolymers with two to six monomer units [43].
Fructosyltransferase from Aureobasidium pullulans was submitted to preparative scale chro‐
matographic separation on a weak anion-exchanger [42]. The molecular weight of the enzyme
determined by size-exclusion chromatography was 570,000. Analysis of the action of FTase on
a FOS substrate (Actilight 950P) showed that sucrose was the only donor of fructosyl moiety
used in the transfer reaction catalyzed by the enzyme, while the acceptor could be another
molecule of fructose or FOS [42].
A transferase isolated and purified from Aspergillus aculeatus exhibited pH and temperature
optima of 6.0 and 60°C, respectively, remaining stable with no decrease in activity after 5 h
under such conditions [44]. The enzyme was monomeric with a molecular mass of 85 kDa. On
the other hand, FFase I from A. pullulans DSM2404 had a molecular weight of 430,000 [45]. The
biocatalyst from A. aculeatus showed both transfructosylation and hydrolytic activity, and the
transfructosylation ratio increased to 88% at 600 mg mL-1 of sucrose [44]. Conditions such as
sucrose concentration (400 mg mL-1), temperature (60°C) and pH (5.6) favored synthesis of
high levels of GF3 and GF4. The major products were GF2 after 4 h and GF4 after 8 h of reaction.
Prolonged incubation for 16 h resulted in the conversion of GF4 into GF2 due to hydrolase
activity.
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The theoretical yield of FOS from sucrose is 75% if 1-kestose is the only FOS produced [46].
However, production yields of FOS are typically low (55–60%) due to the hydrolytic activity
which gives rise to glucose and fructose as reaction byproducts [27] and/or to the fact that
glucose acts as an inhibitor of the enzymes, reducing the reaction efficiency [36,47,48]. To
improve FOS production yields, glucose oxidase has been used to remove glucose via
transformation to gluconic acid [49] and glucose isomerase has been used to interconvert
glucose to fructose [46]. Nevertheless, it is necessary to seek for strains among the microbial
diversity with high transfructosylating activity, able to produce high yields of oligosaccharides
and low yields of monomeric sugars [35].
In addition, the supply of sc-FOS is limited compared to their increasing demand in the food
industry, because enzymes such as fructosyltransferases are not widely commercially available
[50]. For this reason, the production of FOS is usually carried out in a two-stage process, in
which the first stage consists of the microbial production of the enzyme with transfructosyla‐
tion activity, while the second involves the reaction of the produced enzyme with sucrose
(substrate) to generate FOS [29].
A commercial pectinase preparation from Aspergillus aculeatus, Pectinase Ultra SP-L, contains
FTase [51,52] besides being composed of different pectinolytic and cellulolytic enzymes. The
preparation, used in the food industry to reduce the viscosity of fruit juices [42,53], was the
only commercially available source of FTase according to [42].
Enzymes from Aspergillus japonicus, Aspergillus aculeatus (Pectinex Ultra SP-L) and Aureobasi‐
dium pullulans were used to determine the reaction conditions required to obtain high yields
of sc-FOS [34,51,54]. High concentrations of sucrose (600-850 g L-1), pH (4.5–6.5), temperature
(50–60°C), reaction time (3–5 h) and high ratios of transferase and hydrolase activities of the
enzyme favored transfructosylation over hydrolysis reaction [44,53].
In a recent study, twenty-five commercial enzyme preparations used in the food industry were
screened for transfructosylation activity. Three preparations showed high transfructosylation
activity from sucrose, high ratios of transferase over hydrolase activity, selectivity for the
synthesis of sc-FOS and did not hydrolyze the produced sc-FOS after a 12 h reaction time [55].
Among these enzymes, a cellulolytic enzyme preparation, Rohapect CM, catalyzed the
synthesis of sc-FOS with relatively high production yield (63.8%), under cost-effective
conditions of temperature (50°C), sucrose concentration (2.103 M) and enzyme concentration
(6.6 TU/mL), which could provide a process with potential application at industrial scale [50].
The synthesis of FOS from sucrose is economically advantageous because sucrose is less
expensive than inulin; however, the use of enzymes as catalysts for industrial processes is
expensive. Furthermore, the recovery of soluble enzymes for reuse is not economically feasible.
In contrast, enzyme immobilization usually confers high storage and long-term operational
stability, facilitates the recovery and reuse of the biocatalyst, allowing a cost-efficient use of
the enzyme in continuous operation, among other advantages [56,57].
In this context, the commercial enzyme preparation from Aspergillus aculeatus (Pectinex Ultra
SP-L) has been studied for production of FOS in free and immobilized form. Immobilization
of the enzyme onto Eupergit C led to retention of enzyme activity for 20 days of batch
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operation, and both free and immobilized enzyme produced FOS from sucrose with a yield
around 57% [58]. Similarly, production of FOS using the enzyme preparation immobilized
onto epoxy-activated Sepabeads EC (Sepabeads EC-EP5) reached a yield of 61% after 36 h of
reaction [59].
Synthesis of FOS by dried alginate entrapped enzymes (DALGEEs) was recently reported [60].
FTase from Aspergillus aculeatus, contained in Pectinex Ultra SP-L, was entrapped in alginate
gel beads, which were then submitted to dehydration. The dried alginate biocatalysts were
evaluated for the synthesis of FOS from sucrose in a continuous fixed-bed reactor. A 40-fold
enhancement of the space-time-yield of the fixed-bed bioreactor was observed when using
DALGEEs compared with conventional gel beads. The fixed-bed reactor packed with DAL‐
GEEs presented excellent operational stability since the composition of the outlet was nearly
constant during at least 700 h, with an average FOS concentration of 275 g/L.
A partially purified β-fructofuranosidase from the commercial enzyme preparation Visco‐
zyme L was covalently immobilized on glutaraldehyde-activated chitosan particles [61].
Thermal stability of the immobilized biocatalyst was around 100-fold higher at 60°C when
compared to the free enzyme. The biocatalyst also showed a high operational stability, which
allowed its reuse for at least 50 cycles without significant loss of activity. The average yield of
FOS production from sucrose was 55%.
An alternative to the enzymatic production of FOS is the use of either free or immobilized
whole cells in bioreactors [62]. Production of these oligosaccharides via fermentation processes
has the advantage of obviating purification of FOS-producing enzymes from the cell extracts
[29,63,64].
An integrated one-stage method for production of FOS via sucrose fermentation by Aureoba‐
sidium pullulans was developed and optimized with experimental design tools. To maximize
production of FOS, temperature and agitation speed were optimized. A production yield of
FOS from sucrose of 64% was obtained in 48 h of fermentation under the optimum conditions
(32°C and 385 rpm) [62].
Two filamentous fungi, Cladosporium cladosporioides and Penicillium sizovae, with mycelium-
bound transfructosylating activity were recently isolated. C. cladosporioides and P. sizovae
provided maximum FOS yields of 56% and 31%, respectively. C. cladosporioides synthesized a
mixture of FOS (1F-FOS, 6F-FOS and 6G-FOS, including a non-conventional disaccharide
(blastose)) with different glycosidic linkages, which could afford certain benefits regarding
their bioactivity [41].
Two  food  companies  in  Japan  and  Korea  use  different  commercial  processes  for  the
continuous production of FOS with immobilized cells of Aspergillus niger and Aureobasidi‐
um pullulans,  respectively,  both  entrapped in  calcium alginate  gel  [27,63].  Calcium algi‐
nate has also been employed to immobilize mycelia of A. japonicus aiming to establish FOS-
producing processes [65,66].
Immobilization of whole cells of Aspergillus japonicus ATCC 20236 onto different lignocellulosic
materials was also undertaken to produce fructooligosaccharides. Cells immobilized in the
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different support materials showed FOS production and FFase activity ranging from 128.35 to
138.73 g/L and from 26.83 to 44.81 U/mL, respectively. Corncobs were the best support for
immobilization, providing the highest results of microorganism immobilization, FOS and
FFase production. In addition, use of immobilized cells led to higher FOS productivity and
yield, as well as higher transfructosylation over hydrolysis ratio of FFase than free cells [64].
Several important health benefits are associated with the consumption of FOS as food ingre‐
dients. These include modulation of colonic microflora; improvement of the gastrointestinal
physiology; activation of the immune system; enhancement of the bioavailability of minerals;
reduction of the levels of serum cholesterol, triglycerides and phospholipids; and prevention
of colonic carcinogenesis [34,44,67,68].
Among the different FOS, 1-kestose is considered to have better therapeutic properties than
those with higher degree of polymerization [69]. The chain length is an important factor
influencing the physiological effect of the oligomer in the host [69] and fermentation by
bifidobacteria and lactobacilli species [70].
In this context, fermentation of oligosaccharides was evaluated using pure FOS mixtures
containing three FOS species (GF2, GF3 and GF4). Only two oligosaccharides (GF2 and GF3)
were consumed by Lactobacillus strains. Moreover, none of the investigated strains metabolized
the GF4 species, suggesting an intracellular metabolism after the FOS transport [70]. This
transfer apparently involves an ATP-dependent transport system with specificity for a limited
scope of substrates [71].
Moreover, β-fructofuranosidase activity enables bifidobacteria to degrade FOS. Nevertheless,
this property is strain-dependent. Some strains consume both fructose and oligofructose, with
different preferences and degradation rates [72].
FOS can be used as calorie-free and non-carcinogenic sweeteners. 1-Kestose has enhanced
sweetening power compared to other sc-FOS, and 1-kestose-rich sc-FOS syrups can be used
as sugar for diabetics [27,73].
Other types of FOS, such as the levan-type and the neo-FOS, have very promising properties;
however, they are not yet commercially available [53,74,75].
3. Galactooligosaccharides
Lactose is a disaccharide formed by the condensation of glucose and galactose molecules, and
is the most important component of mammalian milk, present in a concentration range from
2.0% to 10%. Lactose can be obtained at industrial scale from whey during cheese production,
with dry weight around 80-85%, using crystallization techniques [76-78]. In the past, whey was
considered a waste, although, nowadays, it is used to produce whey powders products,
improving economic and environmental aspects of the by-products [79].
Lactose presents a great importance for food and pharmaceutical industries, being used in
various food products such as chocolate, confectionary and other processed products, as well
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as carrier of medicines in dry powder inhalation preparations, excipient of tablets [80]. In
humans, lactose can cause abdominal discomfort due to its maldigestion, which reaches
approximately 70% of the world’s adult population [81]. β-Galactosidase (β-D-galactoside
galactohydrolase, E.C. 3.2.1.23) plays an important role in human health because it is able to
catalyze the hydrolysis of lactose in glucose and galactose, and because of that, it is often
referred to as lactase. In addition, the transglycosylation reaction can also occur, in which
galactooligosaccharides (GOS) are produced, and their structures can differ in regiochemistry
of glycosidic linkage and degree of polymerization (Figures 3-5; Tables 1 and 2) [82,83].
Figure 3. Structure of a galactooligosaccharide (GOS) derived from lactose, a β-(1,4) linked galactosyl oligomer (n=1-4),
attached to a terminal glucosyl residue by a β-(1,4) bond. GOS are synthesized by the reverse action of β-galactosidases
on lactose in higher concentrations.
Despite the fact that enzymes such as β-glycosidases and β-glucosidases, which also hydrolyze
carbohydrates, are able to catalyze transglycosylation reactions, β-galactosidase is the most
used enzyme in dairy industry to produce GOS. β-galactosidases from Kluyveromyces sp. and
Aspergillus sp. are the most used in industry because products from those microorganisms are
considered as GRAS [84].
Galactooligosaccharides can be defined as a mixture of substances produced from lactose,
with two to eight saccharide units, in which one of the units is a terminal glucose and the
remaining units  are  galactose  and disaccharides  comprising two units  of  galactose  [85].
Several of these GOS are recognized as prebiotics, because they are non-digestible saccha‐
rides and can be used selectively by bifidobacteria and lactobacilli in human intestine, and
thus improve host health [86, 87].
Conversion of lactose into GOS is catalyzed by β-galactosidases in a kinetically controlled
reaction that involves competition between hydrolysis and transgalactosylation. The thermo‐
dynamically favored hydrolysis of lactose, which generates D-galactose and D-glucose,
competes with the transferase activity that produces a complex mixture of galactose-based di-
and oligosaccharides. Transgalactosylation involves direct galactosyl transfer (intramolecular
reaction) to D-glucose yielding regio-isomers of lactose, and indirect transgalactosylation
(intermolecular) giving rise to disaccharides, trisaccharides, and tetrasaccharides, and
eventually longer GOS. The interaction in the active site of the enzyme differs with the acceptor.
When the acceptor is water, glucose and galactose are formed; whereas if the acceptor is a
sugar, reaction results in GOS [86, 87].
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Therefore, high lactose concentrations and low water contents are favorable for GOS synthesis,
being the initial lactose concentrations the most important factor, independently of the enzyme
source. In general, higher lactose concentrations than 30% are necessary to favor synthesis over
hydrolysis [87]. However, at the same lactose concentrations, different yields of GOS can be
obtained, because β-galactosidases from different sources, with different structures and/or
mechanisms, exhibit different selectivity for water and saccharides. Moreover, GOS yields
depend on process conditions, such as temperature, reaction time, pH and enzyme/substrate
ratio [88]. However, GOS production can be affected by glucose and/or galactose that are
recognized as inhibitors of hydrolysis for many β-galactosidases [89,90].
The reaction time and initial concentration of lactose are considerably important to favor GOS
production, since they are simultaneously synthesized and hydrolyzed by β-galactosidase,
being regulated by the kinetics of synthesis and hydrolysis. Additionally, lactose concentration
can increase formation of GOS due to increased availability of galactosyl and decreased
availability of water [82,91]. Additionally, reverse micelle systems, in which the enzyme is
entrapped in an aqueous micelle surrounded by organic solvent, provide decrease of the
thermodynamic activity of water [92,93]. Chen et al. 2003 [93] reported that the transgalacto‐
sylation capability of low concentrations of β-galactosidase and lactose, operating in reverse
micelles system, was similar to high concentrations of enzyme and substrate in an aqueous
system. Authors also showed that GOS production decreases with the increase in water
content.
Figure 4. Examples of structures of galactooligosaccharides: 4-galactosyl lactose (top) and 6-galactosyl lactose (bottom)
are represented, showing usual regiochemistry differences in galactosyl linkages.
Biotechnological Production of Oligosaccharides — Applications in the Food Industry
http://dx.doi.org/10.5772/60934
39
Production of GOS can be improved increasing the reaction temperature. Lactose has relatively
low solubility at room temperature, which increases with increasing temperature. Therefore
high temperatures are desirable since they allow the increase of lactose concentration [94,95].
Besides the possibility to increase the solubility of subtracts and products, high temperature
is advantageous due to the reduced risk of microbial contamination, lower viscosity and
improved transfer rates [96]. However, this is not a general rule, Boon et al. (1998) [97] reported
that the increase of initial lactose concentration achieved at high temperature does not
influence GOS yield using β-galactosidase from Pyrococcus furiosus. Another problem of
carrying out GOS synthesis at high temperature is the occurrence of Maillard reaction and
enzyme inactivation. Bruins et al. (2003) [95] noted that in addition to enzyme inactivation
with the increase of temperature (80°C or above), Maillard reactions almost doubled the rate
of enzyme inactivation. Therefore, the development of new thermostable enzymes, through
recombinant DNA technology, has been undertaken in order to improve the GOS yield
 
 
Figure 5. Enzymatic synthesis of GOS by transgalactosylation reactions. Transgalactosylation is the transfer of the gal‐
actosyl residue, after the cleavage of lactose, to an acceptor molecule containing a hydroxyl group. When the acceptor
is water (A), a galactose is formed by lactose hydrolysis, whereas if the acceptor is a sugar, a disaccharide or a GOS
may be formed. In intramolecular transgalactosylation (B), galactosyl donor and acceptor are the same (glucose), only
linkage position changes. In intermolecular transgalactosylation (C), there is an enzymatic transfer to another nucleo‐
philic acceptor (Y), which can be all the sugars present in the reaction media, resulting in GOS mixtures.
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[98-102]. Hansson et al (2001) [103] verified an increase of GOS yield due to an increase of
transgalactosylation/hydrolysis ratio by changing a phenylalanine residue to tyrosine in β-
glucosidase from Pyrococcus furiosus, using site directed mutagenesis.
Another strategy to decrease water activity, and carry out catalysis with both high lactose
concentration and temperature, demonstrated by Maugard et al. (2003) [104], is the use of
microwave irradiation. GOS was produced using immobilized β-galactosidase from Kluyver‐
omyces lactis along with organic solvents. In these conditions the selectivity for GOS synthesis
was increased 217-fold, compared to a reaction carried out under conventional heating.
Similarly to temperature, pH value can affect the GOS yield, possibly through the control of
synthesis and degradation [105] According to Huber et al. (1976) [106], that studied β-galac‐
tosidase from Escherichia coli K-12, higher pH values than 7.8 increased transgalactosylation/
hydrolysis ratio, which decreased at lower pH values than 6.0. In contrast, Hsu et al. (2006)
[107] observed that β-galactosidase from Bifidobacterium longum CCRC 15708 exhibits its
maximum activity at pH 7.0. This enzyme was stable between pH 6.5-7.0, and after three hours
in these conditions, 20% of its activity was lost.
In general, oligosaccharides, including galactooligosaccharides, are produced using sucrose
or starch, whey, among other substrates with high quality and low cost. The process designed
to convert raw material into oligosaccharides must be inexpensive and focused on increasing
the productivity and stability of enzymes. In this context, immobilization of biocatalysts can
reduce the process costs due to some advantages; such as possibility to reuse the biocatalyst,
applying a series of batchwise or continuous reactions; the biocatalyst can exhibit more stability
than the native counterpart; besides this, immobilization can reduce costs of downstream, since
separation of the biocatalyst from the product can be minimized [108-110]. Recently, several
authors have employed immobilized β-galactosidase to produce GOS, applying different
strategies with promising results [111-114]. Urrutia et al (2013) [111] immobilized Bacillus
circulans β-galactosidase in glyoxyl agarose. The enzyme did not lose the synthetic capacity,
and retained 92% of its activity along 10 reaction batches, producing 1956 g GOS/g protein at
the end of 10 batches. Palai et al (2014) [112] immobilized β-galactosidase in hydrophobic
polyvinylidene fluoride and the reaction for GOS production was carried out with partial
recirculation loop. Both GOS concentration and selectivity for GOS production increased with
increasing initial lactose concentrations, with maximum GOS production of 30% at 50°C, and
feed flow rate of 0.5 mL/min. A novel economic and efficient method to produce GOS through
cellulose-binding fusion β-galactosidase was developed by Lu et al (2012) [113]. A fusion
protein, formed by β-galactosidase from Lactobacillus bulgaricus L3 and a cellulose binding
domain were employed for immobilization by adsorption onto microcrystalline cellulose. The
immobilization was conducted with efficiency of 61% and the maximum GOS yield was 49%
(w/w). Moreover, enzymatic activity of 85% and yield over 40% (w/w) were maintained after
twenty batches. Warmerdam et al. (2014) [114] carried out GOS production in a packed-bed
reactor using commercial β-galactosidase (Biolacta N5) immobilized on Eupergit C250L. GOS
productivity was six-fold higher in one run in the packed-bed reactor than observed in one
run in a batch reactor.
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Smart polymers have been studied to develop GOS production processes. Poly-N-isopropyl
acrylamide is a thermo-responsive poly-N-isopropyl acrylamide (PNIPAAm), which presents
good solubility in water and distinct phase transition at its lower critical solution temperature
(LCST). It is applied in different areas, such as medicine, biotechnology, and engineering
[115,116]. Based on these advantages, Palai et al (2014) [117] developed a useful bioconjugate
between PNIPAAm and β-galactosidase. The constructed PNIPAAm-β-galactosidase (PNbG)
can be used in catalysis and, after that; it can be easily separated from the solution by heating
at a temperature above its LCST. Further on, Palai et al (2015) [118] continued the GOS
production research using this bioconjugate. A maximum GOS yield of 35 % was obtained at
pH 6 and 40°C. An increase in GOS yield was observed when the temperature was risen from
30 to 40°C. At 45°C or above, after prolonged time, enzyme deactivation occurred. Moreover,
bioconjugates could be reutilized at least ten times; and the separation was done by simple
decantation after addition of 0.05 M NaCl and heating at 40°C.
The use of resting or living cells for GOS production appears to be interesting due to its low
cost when compared to the use of purified enzyme. Despite the complexity of biocatalysis
processes involving whole cells, glucose and galactose can be consumed by them. The
consumption of the monosaccharides is interesting because their presence in foods is unde‐
sirable, since they do not exhibit prebiotic effect, increase caloric value of food, and can inhibit
the activity of certain β-galactosidases [119].
Nevertheless, the use of whole cells can be exploited in order to selectively improve GOS
production [120]. Beta-galactosidase form Aspergillus oryzae was used to produce GOS from
lactose, followed by fermentation with Kluyveromyces marxianus cells, that consumed mono
and disaccharides. GOS with 95% purity containing mostly tri- and tetrasaccharides were
obtained [120]. Association of β-galactosidase and cells can be applied to develop GOS
enriched food products. During yogurt manufacturing, GOS was produced by addition of a
commercial β-galactosidase, since starter and probiotic culture were not able to provide it.
Thus, this yogurt with low lactose content can be useful for lactose intolerant people. Moreover,
GOS was stable during storage, probably because it was not metabolized by microbial culture
and enzyme was inactivated by yogurt pH [121].
Products containing GOS were launched for the first time in Japan in the 1980s. Due to their
various and important health benefits, applications of GOS gradually increased worldwide.
These oligosaccharides can be found in diverse products such as yogurt, bakery products,
beverages, snack bars among others [122]. GOS are able to stimulate the growth of bifidobac‐
teria and lactobacilli in the lumen despite other members of the microbiota that were consid‐
ered potentially harmful. These oligosaccharides can prevent bacterial adherence due to their
properties of mimicking host cell receptors in which bacterial adhesion occurs [123]. GOS can
hinder the development of colon cancer, effect which can be attributed to their capacity of
delaying fermentation processes, and reducing the activity of genotoxic bacterial enzymes
associated with this disease [124]. Mineral absorption can be stimulated by GOS administra‐
tion, and their effect on calcium absorption was verified. GOS can be used to alleviate
constipation, which is relatively common in elderly people and pregnant women. It occurs
due to increased bacterial growth and fecal weight; besides this, short fatty acids stimulate
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intestinal peristalsis and increase osmotic pressure of fecal weight. Moreover, GOS have been
reported as indirectly acting on mucosal and systemic immune activity, and also as having
protective effects against allergic manifestations [125].
4. Chitooligosaccharides
In the last years, studies of production and application of chitooligosaccharides (COS) have
increased due to their biodegradability, biorenewability, biocompatibility, physiological
inertness and hydrophilicity, properties that serve as a basis for the use of COS as functional
food or to preserve food from degradation.
Chitin is one of the most abundant natural compounds on earth and its production is mainly
based on the extraction from marine species (shrimps, crabs, lobsters, krills, etc.) [126]. Chitin
is a copolymer of N-acetyl-D-glucosamine and D-glucosamine units linked by β-(1,4) glyco‐
sidic bonds, where N-acetyl-D-glucosamine units are predominant in the polymeric chain as
shown in Figure 6A [127]. Chitin obtained from natural sources has a complex composition,
containing several minerals, proteins, lipids, pigments and other compounds. Chitosan, an
important derivative from chitin, is the deacetylated form of chitin, where N-acetyl groups are
removed by chemical methods (Figure 6B).
Figure 6. Structures of chitooligosaccharides (n= 3-7), A – Chitin (β-1,4-linked N-acetyl-D-glucosamine residues); B –
Chitosan (β-1,4-linked D-glucosamine polymer).
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A considerable amount of residues from processing of fish and crustaceans, rich in chitin and
chitosan, are considered hazardous wastes and at the same time have high potential commer‐
cial value as raw material [128]. It is possible to obtain chitooligosaccharides from those
residues, after prior demineralization and deproteinization by acid and alkali treatments [129].
Chitooligosaccharides are produced by chemical methods or by enzymatic methods from
chitosan, produced by alkaline N-deacetylation. At industrial scale, the chemical route is used
to produce chitooligosaccharides; however, this methodology presents several disadvantages
such as high cost, low yield due to indiscriminate breaks of the polymer chain, production of
toxic compounds due to modification on the chitin structure, as well as, corrosion and
environmental hazards [130].
The enzymatic process is an attractive solution to overcome the above-mentioned disadvan‐
tages, due to their specific action on the substrate, despite the economic costs. Enzymatic
hydrolysis of chitin or chitosan involves several enzymes: chitinase, chitosanase, lysozyme
and cellulase [131]
According to Mourya et al. (2014) [132], various specific enzymes as chitosanases, chitinases
and other nonspecific enzymes can hydrolyze chitin and chitosan. Action of chitinases and
chitosanases are related to the degree of acetylation of the biopolymers. A novel flow chart for
COS production from chitin employing chitinases and chitosanases has been reported (Figure
7) [130].
Chitnases are chitinolytic enzymes hydrolyzing the glycoside bonds between the sugars,
which have the unique capacity to hydrolyze the GlcNAc-GlcNAc (2-acetamido-2-deoxy-β-D-
glucose) links. Pre-treatment with acid solution is necessary to break down the crystalline
structure of chitin and increase the availability of substrate to the action of enzymes. Chitosa‐
nases are enzymes that hydrolyze chitosan, classified according to the substrate specificity
towards chitosan, which act specifically on the deacetylated (D–D) bonds [133].
In recent years, many scientific papers reported the application of chitinolytic enzymes, from
different microorganisms, for the hydrolysis of chitin and chitosan. Enzymes for hydrolysis
can be free or immobilized in non-toxic and inert supports.
Fernandes de Assis et al. 2010 [134] reported that COS yields of 54% were obtained after 10
minutes of hydrolysis reaction. Initial concentration of chitosan was 1% and the final oligomers
concentration was 5.43 mg/mL. Production yields decreased when hydrolysis reaction time
exceeded 10 minutes.
Gao et al. 2012 [135] determined that the optimal enzyme/chitosan ratio was 7.3 U/mg chitosan
at 55°C to produce COS from chitosan employing chitinases from Bacillus cereus, achieving a
hydrolysis yield of 76%. The yields of COS (GlcN)2, (GlcN)3 and (GlcN)4 were 13.2; 32.6 and
30.2%, respectively.
Ming et al. 2006 [136] producing chitooligosaccharides, reported pH range 4.5-6 as the optimal
for chitinase activity, reaching 20 g/L of chitooligossacharides from an initial concentration of
50g/L of chitosan, which means a system with 40% of yield in the conversion of chitosan into
chitooligosaccharides. Also, employing free and immobilized chitosanase from Bacillus
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pumilus, Kuriowa et al. 2009 [137], produced chitooligosaccharides in batch and continuous
systems. In a system with free enzyme at batch conditions a concentration of 2.8 g/L was
achieved, from an initial concentration of 5g/L after 40 minutes of treatment. Another system
used was a membrane reactor with cutoff 2000Da. Enzyme concentration of 940 U/L, 40
minutes of residence time and 35°C were reported as the optimal conditions to attain 2.6 g/L
of chitooligosaccharides. The membrane bioreactor with the free enzyme was able to maintain
a constant rate of chitooligosaccharides production for 96 hours, after that time concentration
decreased due to inactivation of enzymes. In order to extend the period of operation, the use
of immobilized enzymes was evaluated in the membrane bioreactor. The maximum total
concentration of chitooligosaccharides was 2.3 g/L with 620 U/L of immobilized chitinase
during 1 month, however it is important to point out that yield was 46%, lower when compared
to free enzyme tests.
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Figure 7. Global flow chart for production of COS by enzymatic hydrolysis of chitin and chitosan (adapted from Jung
and Park 2014 [130]).
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COS can be applied as food preservatives due to their antimicrobial activity and as functional
food, mainly in prebiotics and to help the absorption of important minerals, as calcium.
Antimicrobial activity of COS depends on the degree of polymerization (DP) and the degree
of deacetylation (DD) as summarized in Table 1.
Inhibitory effects of COS were tested on both Gram (-) and Gram (+) bacteria, including
Escherichia coli, Pseudomonas fluorescens, Salmonella typhimurium, Vibrio parahaemolyticus, Listeria
monocytogenes, Bacillus megaterium, Bacillus cereus, Staphylococcus aureus, Lactobacillus plantarum,
Lactobacillus brevis and Lactobacillus bulgaricus [138]. Solutions containing 1% (w/v) COS with
different molecular weights inhibited bacterial growth by 1-5 log cycles. For Gram (-) bacteria
the antimicrobial activity was inversely proportional to the molecular size of oligomers, which
means higher antibacterial activity was found with lower molecular weight of oligomers (1
kDa). This phenomenon was not observed for Gram (+) bacteria.
The proposed mechanism of antibacterial activity for COS with DP>12 was cellular lysis [139].
This would be due to the cationic charges of COS that could link to the negative charges present
in the cell walls, leading to the formation of large bacterial clusters, which might block the
nutrition transport across the bacterial cell and result in death of the bacteria. Highly deace‐
tylated COS were shown to be more effective at inhibiting the growth of Staphylococcus
aureus, Escherichia coli, Pseudomonas aeruginosa, Streptococcus fecalis and Samonella typhimurium
than COS with low degree of deacetylation [140].
It has been suggested that COS are able to pass through the bacterial cell wall and be incor‐
porated in the cytoplasm of Gram (+) bacteria [141]. Those low molecular weight compounds
can have importance in gene expression related to regulation of stress, autolysis and energy
metabolism.
Chitooligosaccharides with DP 4 were demonstrated to have higher antimicrobial effect on
four bacteria species (Escherichia coli, Staphylococcus aureus, Streptococcus lactis, Bacillus subtilis)
and six fungi (Saccharomyces cerevisiae, Rhodotorula bacarum, Mucor circinelloides, Rhizopus
apiculatus, Penicillium charlesii, Aspergillus niger) [142]. At the same time, degrees of deacetyla‐
tion over 90% were shown to be more efficient in the inhibition of microbial growth. In
addition, chitooligosaccharides with low molecular weight were able to cross the cell wall and
interact with DNA in the cytoplasm suppressing the growth of microorganisms. Highly
deacetylated COS have many free amines, which can bond to negatively charged residues at
the cell wall, leading to formation of aggregates of microorganisms. Those aggregates precip‐
itate, resulting in death of the microorganism.
Chitooligosaccharides can be employed as preservatives due to their antioxidative properties.
Antioxidant activity of chitooligosaccharides depends on their degree of deacetylation and
molecular weights [143]. It was shown that 90% deacetylated medium molecular weight COS
have the highest free radical scavenging activity for DPPH, hydroxyl, superoxide and carbon
centered radicals [144]. Antioxidant properties are closely related to the amino and hydroxyl
groups, which can react with unstable free radicals to form stable macromolecule radicals
[145,146].
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According to Halden et al. 2013 [147] COS could be applied as feed additives or hypocholes‐
terolemic agents. Based on their study, hypercolesterol concentration in blood is directly
related to the generation of reactive oxygen species. Thus, chitooligosaccharides can be used
to scavenge the free radicals on the body, triggering the enhanced synthesis of catalase and
superoxide dismutase and decreasing lipid peroxidation.
COS were conjugated with phenolic acid (PAC-COS) to improve the antioxidant properties of
the oligosaccharides in the presence of reactive oxygen species (2,2-diphenyl-1-picrylhydrazyl
(DPPH), hydroxyl (OH) and nitric oxide (NO)) [148]. The increase on the antioxidant activity
is associated to the structure of phenolic acids and the substitutions on the aromatic ring of
the side chain.
Chitooligosacharides can be considered as prebiotics because they are non-digestible food
ingredients with beneficial effects on probiotic bacteria (Lactobacillus and Bifidobacterium)
present in the gastrointestinal tract [5]. In fact, prebiotic activities of COS preparations (0.1 to
0.5%) with varying degree of polymerization (2 to 8) were reported [149]. Assays were
conducted with three strains of probiotic bacteria, Bifidobacterium bifidum KCTC 3440, Bifido‐
bacterium infantis KCTC 3249 and Lactobacillus casei KCTC 3109.
However, an opposite effect was shown on the population of Lactobacillus and Bifidobacteri‐
um when chitooligosaccharides were tested as prebiotic agents in healthy rats [150]. Chitooli‐
gosaccharides have been demonstrated to have a weaker prebiotic effect over Lactobacillus and
Bifidobacterium when compared with other oligosaccharides as fructooligosaccharides,
mannanoligosaccharides; and galactooligosaccharides [151].
Chitooligosaccharides from marine species, mainly shrimps and crabs, are produced and
commercialized by several companies (Table 2), such as:
• Qingdao BZ-Oligo Co., Ltd: Monomers of chitosan oligosaccharides are obtained by
enzymatic hydrolysis, chemical derivatization and column chromatography. The degree of
polymerization is from 2 to 10.
• BioCHOS: Preparation of chitooligosaccharides (CHOS) made by controlled enzymatic
degradation of chitosan.
• AMSBIO: Preparation of a series of chitosan-oligosaccharides from dimer to hexamer by
hydrolysis of chitosan from crab shells. All oligomers are chromatographically pure, not
less than 98%, confirmed by high performance liquid chromatography.
5. Novel oligosaccharides
Typical oligosaccharides like FOS and GOS in particular have been widely studied for their
prebiotic effects. However, a number of other non-digestible oligosaccharides (NDOs), to
which less rigorous study has been so far applied, have at least indications of prebiotic
potential. Those with the most accumulated evidence to date are isomalto-oligosaccharides
(IMO), soybean oligosaccharides (SOS), xylo-oligosaccharides (XOS) and lactosucrose.
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Together with FOS, GOS, and lactulose, all of these oligosaccharides are recognized in the
Japanese functional food regulation system as ingredients with beneficial health effects [152].
A great interest resides on the identification, evaluation and commercialization of new
products with improved functional properties and benefic health effects such as higher ability
to modulate microbiota. Arabinoxylo-oligosaccharides (AXOS), levan-type FOS, gentio-
oligosaccharides (GenOS) and pectin-derived oligosaccharides (POS) are examples of these
new potential products.
5.1. Isomalto-oligosaccharides
Isomalto-oligosaccharides are usually found as a mixture of oligosaccharides with predomi‐
nantly α-(1,6)-linked glucose residues with a degree of polymerization (DP) ranging from 2–
6, and oligosaccharides with a mixture of α-(1,6) and occasionally α-(1,4) glycosidic bonds such
as panose (Figure 8; Table 1) [152].
Figure 8. Examples of structures of isomalto-oligosaccharides. Glucosyl residues are linked to maltose or isomaltose by
α-(1,6) glycosidic bonds.
Isomalto-oligosaccharides, like malto-oligosaccharides, are produced using starch as the raw
material. Isomalto-900, a commercial product, is produced from cornstarch and consists of
isomaltose, isomaltotriose and panose. Starch dextrans are easily converted to IMO, which are
the market leaders in the dietary carbohydrate sector of functional foods in Japan. However,
unlike malto-oligosaccharides, there is evidence to suggest that isomalto-oligosaccharides
induce a bifidogenic response [11].
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IMO occur naturally in various fermented foods and sugars such as sake, soybean sauce and
honey. They are a product of an enzymatic transfer reaction, using a combination of immobi‐
lized enzymes. Initially, starch is liquefied using α-amylase (EC 3.2.1.1) and pullulanase (EC
3.2.1.41), and, in a second stage, the intermediary product is processed by both β-amylase (EC
3.2.1.2) and α-glucosidase (EC 3.2.1.20). Beta-amylase first hydrolyzes the liquefied starch to
maltose. The transglucosidase activity of α-glucosidase then produces isomalto-oligosacchar‐
ides mixtures which contain oligosaccharides with both α-(1,6)- and α-(1,4)-linked glucose
residues (Table 2) [153].
In recent years, much research has been focused on improvement of the efficiency of IMO
production by screening for new and better enzymes for high yield IMO synthesis. Efforts also
have been made to develop novel processes such as synthesis of IMO from sucrose using free
or immobilized dextransucrase and dextranase, and efficient conversion of maltose into IMO
using immobilized transglucosidase, or using an enzyme membrane reactor [153,154].
IMO are mild in taste and relatively inexpensive to produce. These oligosaccharides have
desirable physicochemical characteristics such as relatively low sweetness, low viscosity and
bulking properties. IMOs have been developed to prevent dental caries, as substitute sugars
for diabetics [155], or to improve the intestinal flora [152].
Several companies currently manufacture isomaltooligosaccharides, of which Showa Sangyo
(Japan) is the major producer. Of the emerging prebiotic oligosaccharides, IMO are used in the
largest quantities for food applications. In Japan, the volume of IMOs manufactured is
estimated to be three times greater than for either FOS or GOS [152]. Among other oligosac‐
charides, which are widely used as food ingredients or additives [156] based on their nutri‐
tional and health benefits [157], IMO are interesting due to availability, high stability and low
cost [154].
Unlike other prebiotic oligosaccharides, considerable digestion of IMO occurs during intestinal
transit. A large portion of this ingredient reaches the colon and intestinal enzymes degrade
the remainder, leading to a rise in blood glucose levels [154]. Thus, a part of the IMO survives
gastric transit to be fermented by the intestinal microbiota [152]. In vitro fermentation studies
have shown that IMO promote the selective proliferation of bifidobacteria in the fecal micro‐
biota [158]. However, further controlled human feeding studies employing culture and
molecular techniques are required to determine the impact of IMO on the intestinal microbiota.
Beneficial effects of IMO consumption have been reported in a few human feeding studies
investigating health parameters in specific populations. IMOs stimulate bowel movement and
help to decrease total cholesterol levels with an intake of 10 g/d in elderly people [158].The
limited data for physiological effects showed only improved defecation pattern (frequency
and stool bulk via increases in microbial biomass) and lowering of total cholesterol levels
[158,159]. In conclusion, the data for the bifidogenic effects of isomalto-oligosaccharides are
less consistent than for other typical oligosaccharides like inulin or oligofructose [155].
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5.2. Soybean oligosaccharides
Unlike other oligosaccharides, soybean oligosaccharides are extracted directly from the raw
material and do not require enzymatic manufacturing processes. These α-galactooligosac‐
charides include and consist of galactosyl residues linked to the glucose moiety of sucrose by
α-(1,6) bonds (Figure 9,Table 1) [2].
Figure 9. Examples of the main soybean oligosaccharides, raffinose and stachyose, derived from sucrose, showing gal‐
actosyl residues linked to sucrose by α-(1,6) bonds.
Soybean whey, a by-product from the production of soy protein isolates and concentrates, is
composed mainly of raffinose (DP 3), stachyose (DP 4) and verbascose (DP 5), as well as
sucrose, glucose and fructose. The most abundant sugars are extracted from the soybean whey
Food Production and Industry50
and concentrated to produce soybean oligosaccharide syrup (Table 2), rather than being
commercially synthesized using enzymatic processes [158].
Raffinose and stachyose are resistant to digestion, since α-galactosidase activity (required to
hydrolyze these carbohydrates) is not present among human digestive enzymes and, therefore,
reach the colon intact, where they act as prebiotics, stimulating the growth of bifidobacteria.
Apart from being acknowledged as non-digestible, human studies on the effects of these
oligosaccharides are scarce. Their physiological actions appear to be similar to the other
galactooligosaccharides; they are bifidogenic and promote other effects expected from this
change in colon microbiota. Calpis Co. (formerly known as Calpis Food Industry Co.) produces
soybean oligosaccharides in Japan [11].
5.3. Xylo-oligosaccharides
Xylo-oligosaccharides (XOS) are sugar oligomers of xylose units linked by β-(1,4) linkages
(Figure 10,Table 1). The number of xylose residues can vary from 2 to 10, but mainly consist
of xylobiose, xylotriose and xylo-tetraose [152], which are found naturally in bamboo shoots,
fruits, vegetables, milk and honey [160]. In addition to xylose residues, xylans are usually
found in combination with arabinofuranosyl, glucopyranosyl uronic acid or its 4-O-methyl
derivative (2- or 3-acetyl or phenolic substituents), resulting in branched XOS with diverse
biological properties [153].
Figure 10. Partial structure of xylo-oligosaccharides (n=3-6) produced by enzymatic hydrolysis of xylan hemicelluloses,
catalyzed by β-xylanases.
Their production at an industrial scale is carried out from lignocellulosic materials (LCMs).
XOS can be used for several purposes, among them, food-related applications. The LCM for
XOS production comes from a variety of feedstocks (from forestry, agriculture, industry or
urban solid wastes) that show similarities in composition. The raw material for xylo-oligosac‐
charide synthesis is the polysaccharide xylan, which is extracted mainly from corncobs besides
hardwoods, straws, bagasses, hulls, malt cakes and bran [160].
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XOS production from LCM is not simple or economical because it depends on two treatment
steps. The first step is the xylan extraction from LCM, which includes a chemical pretreatment.
Although there are multiple treatments for xylan extraction (alkaline hydrolysis using NaOH,
KOH, Ca(OH)2, ammonia or a mixture of bases, oxidizing agents, salts or alcohols to remove
lignin or pectic substances), there is no favorite consensus among them. Once the extracted
xylan is in a soluble form, the second step includes the xylanase enzymatic reaction or the
hydrolytic degradation of xylan by steam, water or dilute solutions of mineral acids [160]. For
the enzymatic production of XOS, xylan is enzymatically hydrolysed to xylo-oligosaccharides
by endo-β-1,4-xylanases (EC 3.2.1.8) (Table 2). Enzyme complexes with controlled exo-
xylanase and/or β-xylosidase activity are required, to avoid the production of xylose, which
may cause inhibition effects in XOS production. For food related applications, a DP of 2–4 is
the most desirable [160]. Therefore, development of efficient and economical xylanase based
bioprocesses for use in XOS production is necessary. Many microorganisms well known as
producers of xylanolytic enzymes may be promising for novel production processes [161].
The process yields predominantly linear β-(1,4)-linked XOS (mainly xylobiose, xylotriose and
xylotetraose) as well as some oligosaccharides with branched arabinose residues. For the
production of food-grade XOS, a refining step is necessary. Vacuum evaporation increases the
XOS concentration and removes volatile compounds such as acetic acid and the flavours of
their precursors. In order to obtain higher-purity oligosaccharide products, the monosacchar‐
ide xylose and high molecular mass carbohydrates, as well as non-saccharide components can
be removed from the oligosaccharides using membrane filtration techniques, organic solvent
extraction, adsorption in different materials and chromatographic separation techniques used
for XOS purification. Chromatographic methods, however, are not suitable for economic
reasons for large-scale production of XOS intended to be used in the food industry [153].
XOS can be metabolized by bifidobacteria and lactobacilli in pure culture. In relation to human
health, XOS selectively enhanced the growth of bifidobacteria thus promoting a favorable
intestinal environment [152]. XOS is a promising oligosaccharide class that stimulates in‐
creased levels of bifidobacteria to a greater extent than do FOS or other oligosaccharides [161].
However, to date well-controlled animal and human feeding studies to confirm the prebiotic
activity of XOS are still scarce. While they show promise, more research is required before XOS
can conclusively be claimed as prebiotics. Besides the potential prebiotic effect, immunosti‐
mulating effects, antioxidant activity, anti-allergy, anti-infection and anti-inflammatory
properties were reported for XOS [162-164].
In addition to the beneficial health effects, XOS have interesting physicochemical proper‐
ties; they are only moderately sweet, have an acceptable odor, are noncariogenic and low
caloric, stable over a wide range of pH values (2.5–8.0), even the relatively low pH value
of gastric juice, and temperatures up to 100°C. Most oligosaccharides can be hydrolyzed,
resulting in the loss of nutritional and physicochemical properties at acidic pH values, when
treated at  high temperatures for short  periods,  or when submitted to prolonged storage
under room conditions. These properties make them suitable for incorporation into many
food products such as in combination with soymilk, soft drinks, dairy products, sweets and
confectionaries [158].
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XOS show a remarkable potential for practical utilization in many fields, including pharma‐
ceuticals, feed formulations and agricultural applications. Nevertheless, their most important
market developments correspond to food-related applications, however, their comparatively
high production costs impair market development of these oligosaccharides, and further
improvements in process technology are necessary [11].
5.4. Arabinoxylo-oligosaccharides
Arabinoxylo-oligosaccharides (AXOS) are an example of a novel prebiotic dietary fiber. They
can be isolated from wheat bran and consist of xylan chains with a variable substitution of
arabinose side chains (Table 3) [158]. On an industrial scale, AXOS are generated through the
enzymatic cleavage of AX with endoxylanases, resulting in various molecules differing in DP
(between 3 and 67) and degree of substitution of arabinosyl residues [165].
Novel oligosaccharides Chemical structure References
Lactosucrose 4-galactosyl sucrose [2, 156]
Arabinogalactooligosaccharides Galactan oligomers β-(1,3) or (1,6) attached toarabinofuranose residues. [19]
Arabinoxylooligosaccharides Xylan randomly attached to arabinofuranose residuesby α-(1,3) or α-(1,2) linkages. [165, 237]
Arabinooligosaccharides Arabinosyl units linked by α-(1,5) bonds. [2]
Pectic oligosaccharides Linear backbone of α-(1,4) linked D-galacturonic acidunits randomly acetylated and/or methylated. [171, 172,
238, 239]Galacturonan Linear chain of α-(1,4) linked D-galacturonic acids
Rhamnogalacturonan α-(1,4) linked galacturonic acid and α-(1,2) linkedrhamnose units
Mannan oligosaccharides Mannose α-(1,6) linked backbone and α-(1,2) and α-(1,3) linked branches. [176]
Oligodextrans Glucosyl units linked by α-(1,4) bonds.
[176, 240]
Gentiooligosaccharides Glucosyl units linked by β-(1,6) bonds.
Beta-glucan oligosaccharides Glucosyl units linked by β-(1,3/1,4) or β-(1,3/1,6)bonds.
Cyclodextrins α-(1,4) linked cyclic – glucosyl units.
Table 3. Novel oligosaccharides with prebiotic activities.
The fiber properties include an improvement of bowel habit and positive change of the
fermentation in the colon, whereas they were also shown to possess bifidogenic properties
[158]. There are indications that AXOS have an effect against type II diabetes. AXOS decrease
postprandial glucose levels and insulin response, and increase postprandial ghrelin in healthy
humans [156,166].
This bifidogenic effect is strongly influenced by the complexity of the AXOS molecules and
decreases with increasing average DP and degree of substitution [72,166]. Genome sequence
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analysis reveals that several bifidobacterial strains contain genes possibly coding for enzymes
involved in the debranching of side groups and in the cleavage of the xylose backbones of
AXOS [72]. This kind of specialization together with the potential to degrade xylose backbones
intracellularly could explain the selective growth stimulation of bifidobacteria by AXOS.
5.5. Novel fructooligosaccharides
There is an increasing interest in novel molecules with prebiotic and physiological effects.
Some fungi are able to synthesize levan-type FOS containing fructosyl units linked by β-(2,6)
linkages (6-kestose being first in the series) (Table 1), or neolevan type FOS containing a
fructosyl unit also linked by this type of linkage to a glucose (neokestose, neonystose, or
neofructofuranosylnystose). Such FOS have been metabolized by different bifidobacteria
strains when supplied as the sole carbon source [167].
Levan-type FOS were synthesized by acid hydrolysis of β-(2,6)-linked polymers containing a
glucose at one terminus (levans), these have been produced by several microorganisms
growing in sucrose-based medium [168]. The discovery of novel enzymes that synthesize β-
(2,6)-linked FOS from sucrose may, however, provide a non-pollutant alternative to acid
hydrolysis of levans. Because there is an existing process to produce inulin-type FOS, an
enzymatic method involving the hydrolysis of levan to produce levan-FOS may be possible.
However, with the lack of an available plant source of levan, as there is for inulin, it is possible
to derive an enzymatic process to produce levan-type FOS from microbial levan, using
levansucrase (Table 2) and endolevanases [169].
Marx et al. 2000 [170] observed that levan-type FOS obtained via the acid hydrolysis of levans
were metabolized by different bifidobacteria strains, thus further demonstrating their prebiotic
potential. Nevertheless, the levan-type FOS prebiotic properties have not been fully charac‐
terized, possibly due to their limited availability.
The production of levan-type FOS has not reached industrial levels [171], despite several
reports demonstrating their potential applications as food and feed additives in agriculture as
well as their pharmaceutical applications.
5.6. Pectic oligosaccharides
Pectic oligosaccharides (POS) (Table 3) are obtained by pectin depolymerization. Pectins are
ramified heteropolymers made up of a linear backbone of α-(1,4)-linked D-galacturonic acid
units (which can be randomly acetylated and/or methylated).
POS have been proposed as a new class of prebiotics capable of exerting a number of health-
promoting effects. Among these are protection of colonic cells against pathogenic microor‐
ganisms [172], stimulation of apoptosis of human colonic adenocarcinoma cells [173] and in
vivo synergistic empowerment of immunomodulation caused by galactooligosaccharides
(GalOS) and fructooligosaccharides (FOS). Other benefits include potential for cardiovascular
protection in vivo, reduction of damage by heavy metals, antiobesity effects, dermatological
applications and antitoxic, antiinfection, antibacterial and antioxidant properties. Additional‐
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ly, in vivo and in vitro studies have confirmed that acidic POS are not cytotoxic or mutagenic,
being suitable for use in foods for children and babies [173].
5.7. Gentio-oligosaccharides
Gentio-oligosaccharides (GenOS) consist of 2–5 glucose residues linked by β-(1,6) glycosidic
linkages (Table 3). These oligosaccharides are not hydrolysed in the stomach or small intestine
and therefore reach the colon intact, thus fulfilling a criterion of a prebiotic [11]. GenOS were
further reported to possess bifidogenic activity [153]. GenOS are usually produced from
glucose syrup by enzymatic transglucosylation or by biocatalytic glycosylation with cultured
cells. Despite the prebiotic potential of GenOS, research on the novel production of GenOS is
sparse. Gentio-oligosaccharides are produced in Japan by Nihon Shokuhin Kako [11].
6. Perspectives
Function and application of chitooligosacharides frequently depend on their size, and,
therefore, the degrees of polymerization and acetylation. Substrate-enzyme synergisms
determine the molecular weight of the generated COS. Gutierrez-Román et al. 2014 [174] tested
three chitolytic enzymes ChiA, ChiB and ChiC, alone and in combination. In addition, three
chitanases were tested in synergism with a chitobiase and a non-catalytic binding protein.
When evaluated individually, ChiA was unable to hydrolyze chitin while ChiB and ChiC were
able to degrade chitin and generate chitin monomers and dimers. When enzymes were tested
pairwise (ChiA-ChiB, ChiA-ChiC, and ChiB-ChiC) the production of dimers and trimers was
much higher, and monomers significantly lower than those seen with ChiB or ChiC individ‐
ually. However, higher concentrations of COS were obtained when the authors tested the four
enzymes in combination with non-catalytic binding protein acting on chitin.
Further studies must be focused on the action of the enzymes on substrates with different
degrees of polymerization and acetylation and N-acetylation pattern to improve the compre‐
hension of that synergism. In addition, researches involving synergism of non-catalytic
binding proteins and hydrolytic enzymes should be developed in order to increase the
understanding of oligomers syntheses [127]. Consequently, to produce size-specific chitooli‐
gosaccharides by enzymatic hydrolysis, further studies on genetic modification are necessary
to overproduce enzymes and non-catalytic binding proteins, which will have a great impact
on the quality of oligomers obtained and on the productivity of industrial processes.
Another important challenge in the development of biotechnological processes that employ
agro-food industry residues as raw material is the direct fermentation of those raw materials.
Obviously, direct fermentation of raw materials is closely related with the aforementioned
aspects, since fermentative processes involve microbial growth and enzymatic hydrolysis, and
process conditions that in many cases are different from physiological conditions. Moreover,
it is important to give attention to screening of new enzymes from extremophile microorgan‐
isms, which usually catalyze reactions under non-physiological conditions such as high
salinity, high temperature and low water activity [175].
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As important part of the biotechnological process, bioreactors and enzyme (free or immobi‐
lized) are essential and need special attention to improve yields and productivities. Free
enzymes in batch systems are the most conventional technology employed in the production
of oligosaccharides by enzymatic hydrolysis. However, it has several important drawbacks,
because enzymes are unstable, can be employed once and accumulation of products usually
reduces their activity. These drawbacks are related directly to the quality of the product and
the yield of the process. Development of novel technologies in order to solve those snags
employing immobilized enzymes in column reactor and membrane systems have been
studied. Column reactor packing with immobilized enzymes allows continuous production
of oligosaccharides and has important advantages, such as increased operational stability of
the enzyme and reduced accumulation which otherwise could lead to enzyme inhibition. The
poorer affinity of immobilized enzymes is the main disadvantage of the application of column
reactors at industrial scale. Studies should be directed towards the improvement of enzyme-
support affinity. Membrane reactors are considered a new and attractive technology to
produce oligosaccharides, in which enzymes are confined in the reaction side and continuously
reused, with obvious implications for the efficiency and economy of the process. Low-cost and
low-energy consumption are other important advantages to increase its utilization. The main
limitation for industrial application of membrane reactors are fouling and polarization
phenomena, which decrease considerably permeate flux, containing the produced oligosac‐
charides [176]. The main challenge to be studied in order to implement this technology
advantageously in the industry is how to reduce the effect of these problems without affecting
the stability of enzymes.
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